Sabeena Ahmed
Overview
Explore the profile of Sabeena Ahmed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
604
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shannon K, Shields T, Ahmed S, Rahman H, Prue C, Khyang J, et al.
Am J Trop Med Hyg
. 2022 Sep;
107(6):1210-1217.
PMID: 36122682
Mapping asymptomatic malaria infections, which contribute to the transmission reservoir, is important for elimination programs. This analysis compared the spatiotemporal patterns of symptomatic and asymptomatic Plasmodium falciparum malaria infections in...
2.
3.
Rager T, Koepfli C, Khan W, Ahmed S, Mahmud Z, Clayton K
J Med Internet Res
. 2021 May;
23(5):e22973.
PMID: 33978590
Background: Cholera poses a significant global health burden. In Bangladesh, cholera is endemic and causes more than 100,000 cases each year. Established environmental reservoirs leave millions at risk of infection...
4.
Do N, Vu H, Nguyen C, Punpuing S, Khan W, Gyapong M, et al.
Lancet Glob Health
. 2021 Mar;
9(5):e610-e619.
PMID: 33713630
Background: Antimicrobial misuse is common in low-income and middle-income countries (LMICs), and this practice is a driver of antibiotic resistance. We compared community-based antibiotic access and use practices across communities...
5.
Ahmed S, Karim M, Ross A, Hossain M, Clemens J, Sumiya M, et al.
Int J Infect Dis
. 2020 Dec;
103:214-216.
PMID: 33278625
Ivermectin, a US Food and Drug Administration-approved anti-parasitic agent, was found to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in vitro. A randomized, double-blind, placebo-controlled trial was conducted...
6.
Matin M, Khan W, Karim M, Ahmed S, John-Langba J, Sankoh O, et al.
J Pharm Policy Pract
. 2020 Jun;
13:20.
PMID: 32514362
Background: Antibiotic resistance poses a great threat to global health, especially in low- and middle-income countries with a high infectious disease burden and limited resources. In spite of regulations, antibiotics...
7.
Shannon K, Khan W, Sack D, Alam M, Ahmed S, Prue C, et al.
Int J Infect Dis
. 2016 Jun;
49:161-9.
PMID: 27350586
Objectives: An analysis of the risk factors and seasonal and spatial distribution of individuals with subclinical malaria in hypoendemic Bangladesh was performed. Methods: From 2009 to 2012, active malaria surveillance...
8.
Khan W, Saha D, Ahmed S, Salam M, Bennish M
PLoS One
. 2015 Aug;
10(8):e0134921.
PMID: 26271050
Objective: We identified a poor clinical response to treatment of cholera with a single 1 g dose of ciprofloxacin, a standard treatment for cholera. Methods: To determine reasons for the...
9.
Shannon K, Ahmed S, Rahman H, Prue C, Khyang J, Ram M, et al.
Am J Trop Med Hyg
. 2015 Jun;
93(2):281-6.
PMID: 26101273
Hemoglobin E is largely confined to south and southeast Asia. The association between hemoglobin E (HbE) and malaria is less clear than that of hemoglobin S and C. As part...
10.
Khan W, Galagan S, Prue C, Khyang J, Ahmed S, Ram M, et al.
PLoS One
. 2014 May;
9(5):e98442.
PMID: 24858193
Background: Pregnancy is a known risk factor for malaria which is associated with increased maternal and infant mortality and morbidity in areas of moderate-high malaria transmission intensity where Plasmodium falciparum...